Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses.
about
Neuropeptide regulation of signaling and behavior in the BNST.Cell type-specific modifications of corticotropin-releasing factor (CRF) and its type 1 receptor (CRF1) on startle behavior and sensorimotor gatingAcute engagement of Gq-mediated signaling in the bed nucleus of the stria terminalis induces anxiety-like behavior.Functional Heterogeneity in the Bed Nucleus of the Stria Terminalis.Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviorsThe CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle.Don't stress about CRF: assessing the translational failures of CRF1antagonists.Corticotropin-releasing factor modulation of forebrain GABAergic transmission has a pivotal role in the expression of anabolic steroid-induced anxiety in the female mouse.The role of PKC signaling in CRF-induced modulation of startle.Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouseAnxiogenic effects of CGRP within the BNST may be mediated by CRF acting at BNST CRFR1 receptors.BDNF-dependent consolidation of fear memories in the perirhinal cortex.Phasic and sustained fear are pharmacologically dissociable in rats.Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal modelsRestraint stress-induced reduction in prepulse inhibition in Brown Norway rats: role of the CRF2 receptorPhasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxietyEffect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fearSelective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responsesDistinct forms of Gq-receptor-dependent plasticity of excitatory transmission in the BNST are differentially affected by stress.Differential effects of controllable and uncontrollable footshock stress on sleep in miceIncubation of conditioned fear in the conditioned suppression model in rats: role of food-restriction conditions, length of conditioned stimulus, and generality to conditioned freezing.Distribution and functional expression of Kv4 family α subunits and associated KChIP β subunits in the bed nucleus of the stria terminalis.Stress-induced reinstatement of alcohol-seeking in rats is selectively suppressed by the neurokinin 1 (NK1) antagonist L822429.The central nucleus of the amygdala and corticotropin-releasing factor: insights into contextual fear memory.New dimensions in the use of rodent behavioral tests for novel drug discovery and development.Probing for Neuroadaptations to Unpredictable Stressors in Addiction: Translational Methods and Emerging Evidence.Corticotropin releasing factor type-1 receptor antagonism in the dorsolateral bed nucleus of the stria terminalis disrupts contextually conditioned fear, but not unconditioned fear to a predator odor.Oxytocin receptor neurotransmission in the dorsolateral bed nucleus of the stria terminalis facilitates the acquisition of cued fear in the fear-potentiated startle paradigm in rats.Sex differences in circuits activated by corticotropin releasing factor in rats.Early adolescent stress-induced changes in prefrontal cortex miRNA-135a and hippocampal miRNA-16 in male rats.
P2860
Q26866326-040C4CCF-719E-454B-8F71-2BDB4BF94B1CQ27304423-F0D4F87D-D32A-42A0-AB44-FF222EFD515BQ30354401-9978E54F-C3EA-4BAB-84A8-57D6B066870CQ30364174-280C8C34-8B31-418D-8C52-587EFE5DD476Q30364736-DD5F03F2-2D92-4AB4-8557-C21FC3BB96FCQ30387331-22978D38-79A4-46A5-8D3B-A92A46BCBF75Q30399543-4F45685F-7C98-4032-84C7-4F339C113E1FQ30419669-C995667B-0D13-44D7-9EE4-649C8B504A43Q30429995-F4092212-E3EE-4320-B7CF-EC28550849EEQ30430100-64E56206-E008-4B51-B46D-41AA46B30E64Q30440074-803A16DB-59A3-4CF2-86AE-39EF644E3973Q30445254-B662B2F9-5739-413C-811C-4A981A6697DDQ30466236-9AFECDE8-8DA6-4602-AEC4-C75E5029951DQ30466695-72DBC921-01A1-4094-B3AB-C0AF962E2BCCQ30470071-FF2F9C1A-58DD-475A-8FF8-9CD4CF812D7CQ30477934-73406BC1-9A97-47A3-A103-533B1BFEDBEDQ30477987-0AE83180-976F-4065-95FA-C8DED303AB40Q30478689-E2865CEA-DA6F-45FA-BDC9-7EA92BCFE603Q30493585-CFAC21D5-6274-4EAF-B670-60732D1AFB11Q33830910-4C7DDE0B-B458-4506-85EE-0E676FED66ECQ34062489-0D0EB6E4-09D8-49CE-9C8D-D9EEE33DCE28Q34133151-5391D60B-C531-455E-B7D6-E1EA3BC496BBQ35332004-C8300DE3-919C-4B04-8DF8-87B0F53FBC48Q37408434-2E5D9134-E1A6-41D0-A7DA-F3FAD7327E9FQ38740954-2ADC01B4-AD76-406E-90F4-A0A5D2029045Q39302789-B9B54A05-C423-4606-814F-8185D0D87538Q41852484-1F230DCE-33BE-4D5C-8507-5C5936A9E142Q47324152-1EF7534A-E08C-4C4E-A666-FA36AAC961C7Q47607724-796F49BF-209C-44FD-AA97-34DB262E6446Q48098440-9F96D7B7-4366-4DFF-8864-FBC007441A9F
P2860
Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Differential effects of the CR ...... ed vs phasic threat responses.
@ast
Differential effects of the CR ...... ed vs phasic threat responses.
@en
type
label
Differential effects of the CR ...... ed vs phasic threat responses.
@ast
Differential effects of the CR ...... ed vs phasic threat responses.
@en
prefLabel
Differential effects of the CR ...... ed vs phasic threat responses.
@ast
Differential effects of the CR ...... ed vs phasic threat responses.
@en
P2093
P2860
P356
P1476
Differential effects of the CR ...... ed vs phasic threat responses.
@en
P2093
David Trist
David Walker
Emiliangelo Ratti
Mauro Corsi
Michael Davis
P2860
P2888
P304
P356
10.1038/NPP.2008.210
P407
P577
2008-12-10T00:00:00Z
P5875
P6179
1032239332